Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Still Waiting For Volatility’s Return

Published 09/06/2016, 06:07 AM
Updated 07/09/2023, 06:31 AM

T2108 Status: 57.9%
T2107 Status: 74.2%
VIX Status: 12.0 (fell 11.1%)
General (Short-term) Trading Call: cautiously bearish
Active T2108 periods: Day #139 over 20%, Day #45 over 30%, Day #44 over 40%, Day #43 over 50% (overperiod), Day #6 under 60% (underperiod), Day #21 under 70%

Commentary
After my last T2108 Update, I eagerly awaited a long overdue eruption of volatility. I am still waiting. After Friday’s jobs report missed “expectations,” volatility took a dive off the deep end and left intact the ceiling at the critical 15.35 pivot.

Back to the drawing board for the volatility index, the VIX

Back to the drawing board for the volatility index, the VIX.

Along with the plunge in volatility, the S&P 500 (SPDR S&P 500 (NYSE:SPY)) gapped back into the middle of the current trading range. The move left behind two straight days where sellers seemed to be ready to break the index down only to stumble and fall as buyers rallied the index off its lows for the day.

The SPX continues to float along in an extending trading range

The S&P 500 continues to float along in an ever-extending trading range.

During that time, T2108, the percentage of stocks trading above their respective 40-day moving averages (DMAs), took some serious technical hits. T2108 traded as low as 48.3% on Thursday, September 1, and closed that day at 52.3%. The bearish divergence widened ever further.

T2108 closed the week at 57.9%. The good news for bulls and buyers is that, T2107, the percentage of stocks trading above their respective 200DMAs, has remained remarkably calm throughout all this churn. T2107 has drifted within a tight two percentage point range since it recovered from early August’s brief tumble. My short-term trading bias is still cautiously bearish given the earlier described divergence and the tendency for September to deliver the biggest drawdowns of the year.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


T2108’s downtrend exposes deterioration of short-term technicals

T2108’s downtrend exposes an on-going deterioration of short-term technicals for the general stock market.

T2107’s steady hand indicates longer-term health of the market

T2107’s steady hand indicates the longer-term health of the stock market remains remarkably intact.

Central bank and OPEC action looks set to dominate the scene for September. This week kicks things off with the Reserve Bank of Australia on September 6th and the European Central Bank (ECB) on September 8th. As these events roll out, currencies may become the forcing function for stocks. In the meantime, here are some stock charts to consider this week…

I wrote comprehensively about Mylan NV (NASDAQ:MYL) and its EpiPen pricing debacle last week. I predicted further selling ahead and collateral damage for the iShares Nasdaq Biotechnology (NASDAQ:IBB). Two-for-two so far although IBB is holding up to the Clinton Bash Part Two a lot better than I expected. Perhaps the market has already priced in its Clinton fears from last year. I hope to soon cover two epinephrine-related companies Impax Laboratories (NASDAQ:IPXL) and Adamis Pharmaceuticals (NASDAQ:ADMP).

The selling accelerated on Mylan

The selling accelerated on Mylan (MYL).

IBB is barely clinging to converged support at its 50 and 200DMAs

The iShares Nasdaq Biotechnology (IBB) is barely clinging to converged support at its 50 and 200DMAs. One more slip could trigger a cascade of selling pressure.

On Friday, August 26, Nightly Business Report (NBR) featured U.S. Concrete (NASDAQ:USCR) as a stock pick from a fund manager. I put the company on my potential buy list but have hesitated given the sudden appearance of high-volume selling. I have yet to find explanatory news, but I have duly noted that the stock is technically a short, given how well the 200DMA has held up as resistance. The high-volume selling seems to confirm USCR as a short. I need to see much more constructive action before pulling the trigger for a buy at some point in the future.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

USCRL Looks Like a don't buy/sell/short here

Since an early August gap down, sellers and resistance have dominated the action on U.S. Concrete (USCR). It looks like a don’t buy/sell/short here.

Start at the 15:57 mark…

Tableau Software (NYSE:DATA) has erased about half of its big gain from August 23rd. This looks like a classic “calm after the storm” trade setup. Although I am bearish on the stock market, I am keeping an eye on this setup. If it fails, I might short DATA in anticipation of a complete gap fill and/or retest of 50DMA support. (See here for description of previous setup on DATA).
Buyers have yet to follow-through on the big gap up for DATA

Buyers have yet to follow-through on the big gap up for Tableau Software (DATA), but the selling is drifting and non-committal. A return of buyers could lead to a swift resumption of momentum or a continued absence of buyers could motivate more determined selling.

About a month ago, I concluded that the Teucrium Corn ETF (NYSE:CORN) would continue to sell-off. After a brief pop, CORN did indeed set new all-time lows. Buyers returned over the past two days, and CORN is looking interesting again.

I will stay patient and wait to see whether the ETN can even manage to a close above 50DMA resistance before I consider any kind of purchase. Readers recall that I typically exempt commodities from my general stock market trading call since they can be uncorrelated to stock market returns.
Can buyers sustain the latest CORN bounce?

Sellers have placed intense pressure on Teucrium Corn ETF (CORN). Can buyers sustain the latest bounce?

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The earlier contrary excitement over retailers has cooled off and even reversed in many cases. Macy’s (NYSE:M) led the way by cratering through its 200DMA. The stock is now trying an important bounce from 50DMA support. The SPDR S&P Retail ETF (NYSE:XRT) is also trying to find support at its 50DMA. If I were not bearish, I would look to buy XRT here.

Instead, I am watching for a breakdown to sell. JC Penney (NYSE:JCP) is also testing important 50DMA support. The stock was a big, undervalued pick by the fund manager on NBR August 26th:

“I’m telling you, this is one of the biggest turnaround stories I have come across in my 30 years.”

The bad news is good news trade looks just about over for Macy’s
The bad news is good news trade looks just about over for Macy’s (M). Can buyers defend support at the 50DMA?

XRT is also trying to hold support at its 50DMA

The SPDR S&P Retail ETF (XRT) is also trying to hold support at its 50DMA. However a double-top for 2016 may already be a lock.

JCP is also testing critical 50DMA support

Imagine that – JC Penney Company (JCP) is also testing critical 50DMA support.

The Hain Celestial Group, Inc. (NASDAQ:HAIN) broke down to a new post-earnings low and is now a short.
HAIN is breaking down in the “open field”

The Hain Celestial Group, Inc. (HAIN) is breaking down in the “open field.” A retest of 2016’s low is in play.

Twitter (NYSE:TWTR) survived a test of 200DMA support. The stock now looks ready to overwhelm the two sell ratings that smacked it off its last perch.
TWTR rebounds off 200DMA support

Twitter (TWTR) rebounds off 200DMA support. Can it “defeat” the 2 recent sell ratings?

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Post-earnings sellers in Palo Alto Networks (NYSE:PANW) stopped neatly at 50DMA support. Buyers took over from there. They rushed right into the gap but now face 200DMA resistance. Which is it? Were earnings bad or good?
PANW is struggling to regain its former luster

Palo Alto Networks (PANW) is struggling to regain its former luster as an unstoppable stock. Resistance at its 200DMA may be the ultimate dividing line between breakout and resignation.

One final trading note, I sold my call options in the iShares Silver Trust (NYSE:SLV) as part of a hedged trade for last week. The precious metals did not move nearly as much as I had hoped (open or down). The profits from the SLV call options cover most of the cost of my call options on ProShares UltraShort Silver (NYSE:ZSL). If SLV manages to breakout above 50DMA resistance, I will likely jump right back into call options and get much more aggressive.

SLV springs back to life and makes a challenge for 50DMA resistance

The iShares Silver Trust (SLV) springs back to life and makes a challenge for 50DMA resistance.

Daily T2108 vs the S&P 500
Daily T2108 Vs The S&P 500

Black line: T2108 (measured on the right); Green line: S&P 500 (for comparative purposes)

Red line: T2108 Overbought (70%); Blue line: T2108 Oversold (20%)

Weekly T2108
Weekly T2108

Be careful out there!

Disclosure: long SDS, long UVXY shares, long MYL puts, long IBB puts, long HAIN puts, short TWTR puts, long SLV, long ZSL puts

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.